T cell–derived inducible nitric oxide synthase switches off TH17 cell differentiation by Yang, Jianjun et al.
 T cell–derived inducible nitric oxide synthase switches off TH17 cell
differentiation
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Yang, J., R. Zhang, G. Lu, Y. Shen, L. Peng, C. Zhu, M. Cui, et al.
2013. “T cell–derived inducible nitric oxide synthase switches off
TH17 cell differentiation.” The Journal of Experimental Medicine
210 (7): 1447-1462. doi:10.1084/jem.20122494.
http://dx.doi.org/10.1084/jem.20122494.
Published Version doi:10.1084/jem.20122494
Accessed February 19, 2015 3:12:18 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879570
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Article
The Rockefeller University Press $30.00
J. Exp. Med. 2013 Vol. 210 No. 7 1447-1462
www.jem.org/cgi/doi/10.1084/jem.20122494
1447
IL-17–producing T helper cells (TH17) are a re-
cently identified T helper cell subset, which is 
clearly distinct from TH1 and TH2 cells. TH17 
cells mediate proinflammatory and autoimmune 
responses through the production of TH17 sig-
nature cytokines including IL-17A, IL-17F, and 
IL-22 (Liang et al., 2006; Weaver et al., 2006; 
Bettelli et al., 2007; Zheng et al., 2007). Synergy 
between the cytokines TGF- and IL-6 induces 
in vitro development of TH17 cells (Veldhoen 
et al., 2006; Korn et al., 2007; Nurieva et al., 
2007; Zhou et al., 2007), whereas IL-23 pro-
motes the survival and expansion of TH17 cell 
populations (Bettelli et al., 2006; Mangan et al., 
2006; Veldhoen et al., 2006; Weaver et al., 
2006). RORt, a member of the orphan nuclear 
receptor family, has been identified as the master 
transcription factor for TH17 cell development 
(Ivanov et al., 2006). Other transcription factors, 
including ROR, STAT3, IRF4, and IRF8, 
are also involved in the control of TH17 cell dif-
ferentiation (Ouyang et al., 2011). In addition, 
the differentiation of TH17 cells is also regulated 
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RORt is necessary for the generation of TH17 cells but the molecular mechanisms for the 
regulation of TH17 cells are still not fully understood. We show that activation of CD4+ T cells 
results in the expression of inducible nitric oxide synthase (iNOS). iNOS-deficient mice dis-
played enhanced TH17 cell differentiation but without major effects on either TH1 or TH2 cell 
lineages, whereas endothelial NOS (eNOS) or neuronal NOS (nNOS) mutant mice showed 
comparable TH17 cell differentiation compared with wild-type control mice. The addition of 
N6-(1-iminoethyl)-l-lysine dihydrochloride (L-NIL), the iNOS inhibitor, significantly enhanced 
TH17 cell differentiation, and S-nitroso-N-acetylpenicillamine (SNAP), the NO donor, dose-
dependently reduced the percentage of IL-17–producing CD4+ T cells. NO mediates nitration 
of tyrosine residues in RORt, leading to the suppression of RORt-induced IL-17 promoter 
activation, indicating that NO regulates IL-17 expression at the transcriptional level. Finally, 
studies of an experimental model of colitis showed that iNOS deficiency results in more severe 
inflammation with an enhanced TH17 phenotype. These results suggest that NO derived from 
iNOS in activated T cells plays a negative role in the regulation of TH17 cell differentiation and 
highlight the importance of intrinsic programs for the control of TH17 immune responses.
© 2013 Yang et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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isoforms of NO synthase (NOS) have been identified: neuro-
nal NOS (nNOS), inducible NOS (iNOS), and endothelial 
NOS (eNOS; Griffith and Stuehr., 1995). It has been demon-
strated that NO plays many important roles in neurotransmis-
sion, vascular functions, host defense, and immune regulation 
(Bogdan, 2001; Calabrese et al., 2007). These enzymes are 
products of different genes, with different regulation, localiza-
tions, and catalytic properties. nNOS and eNOS are primarily 
expressed in neurons and endothelial cells, and they are cal-
cium dependent. iNOS can be induced by cytokines and 
other stimuli in many cell types and it is calcium independent. 
It is clear that NO is an important proinflammatory cytotoxic 
mediator that defends the host against various pathogens by 
inactivating and destroying infectious agents (Bogdan et al., 
2000). Interestingly, NO also plays critical roles in immune 
suppression (Xiong et al., 1996; Niedbala et al., 2006). Pre-
viously, we and other groups reported that NO suppresses 
IL-12 production from dendritic cells and macrophages (Xiong 
et al., 2004), suggesting that NO may control the generation 
of TH1 immune responses by regulating IL-12 expression. 
by several positive- and negative-feedback loops involving 
IL-21, IL-23R, IL-10, and IL-27 (Harrington et al., 2005; 
Stumhofer et al., 2006; Korn et al., 2007; Nurieva et al., 2007; 
Gu et al., 2008; Yang et al., 2008; McGeachy et al., 2009), in-
dicating that intrinsic genetic programs may contribute to the 
regulation of TH17 lineage commitment.
There is increasing evidence that TH17 cells are involved in 
the pathogenesis of various autoimmune/inflammatory dis-
eases, including multiple sclerosis (MS), rheumatoid arthritis 
(RA), inflammatory bowel diseases (IBDs), and asthma (Korn 
et al., 2009). Thus, a more complete understanding of the mo-
lecular mechanisms involved in the regulation of TH17 immune 
responses should provide insights into the pathogenesis and 
treatment of these and possibly other inflammatory diseases. 
Although the activation program for TH17 cell differentiation 
has been well established, the intrinsic down-regulation for 
TH17 cell differentiation has not been fully understood.
Nitric oxide (NO) is one of the smallest known bioactive 
products of mammalian cells and it can be produced by many 
mammalian cell types (Moncada et al., 1991). Three distinct 
Figure 1. Enhanced TH17 cell differentiation in iNOS-deficient mice. (A) Naive CD4+ T cells from WT or iNOS/ mice were differentiated  
under TH0 and TH17 polarizing conditions for 3 d. Cells were then restimulated with PMA/ionomycin for 5 h, stained for intracellular IL-17 and analyzed  
by flow cytometry. Representative FACS dot plots gated on CD4+ T cells and the percentages of IL-17–producing CD4+ T cells are shown. Each bar  
represents mean ± SD from three independent experiments. *, P < 0.05 versus iNOS/ cells. (B) The cells prepared in A were restimulated with PMA/ 
ionomycin for 12 h and the supernatants were analyzed for IL-17 and IL-22 by ELISA. Each bar represents mean ± SD of at least three independent mea-
surements. (C) The cells prepared in A were restimulated with PMA/ionomycin for 5 h and mRNA expression of indicated genes was determined by qPCR. 
Data present mean ± SD of measurements from two independent experiments, performed in triplicate. The data shown were normalized to levels of ubiqui-
tin expression as analyzed by qPCR. *, P < 0.05 versus iNOS/ cells. (D) Thymus and spleen cells from iNOS/ and WT controls were prepared and the cells 
were stained for surface CD4 and CD8 and analyzed by flow cytometry. The data shown were normalized to levels of ubiquitin expression as analyzed by 
qPCR. *, P < 0.05 versus iNOS/ cells. The results are representative of three independent experiments.
JEM Vol. 210, No. 7 
Article
1449
Transfer of naive T cells from iNOS-deficient mice induced 
more severe colitis in Rag1/ mice than T cells from normal 
controls. These findings suggest that NO plays a critical sup-
pressive role in the control of TH17 differentiation and high-
light the importance of T cell–derived iNOS in switching off 
TH17-dependent immune responses.
RESULTS
iNOS deficiency enhances TH17 cell differentiation
To investigate the function of NO in TH17 cell differentia-
tion, we first assessed the characteristics of CD4+ T cells from 
iNOS-deficient mice. Naive CD4+ T cells from iNOS/ or 
WT control mice were primed in vitro for 3 d under neutral 
(TH0) or TH17 (IL-6 plus TGF-) polarizing conditions. The 
cells were then restimulated with PMA/ionomycin and ex-
amined for the percentages of IL-17–producing cells by intra-
cellular staining using flow cytometry. Notably, the frequency 
of IL-17–producing cells generated from iNOS/ T cell 
cultures was significantly greater than cells from WT cultures 
(Fig. 1 A). These observations correlated with enhanced 
In addition, iNOS-deficient mice are more susceptible than 
WT mice to the development of inflammatory diseases such as 
EAE (Bogdan., 1998; Niedbala et al., 2011). More and more 
evidence indicates that NO affects T helper cell differentiation 
(Nath et al., 2010; Lee et al., 2011; Niedbala et al., 2011), sug-
gesting that NO may dictate T cell immune responses. How-
ever, it is still not clear whether T cells express NOS, and if so, 
what functions T cell–derived NO might serve.
In the present study, we show that mice deficient in iNOS 
exhibited enhanced TH17 cell differentiation while exhibiting 
no significant effects on TH1 or TH2 cells. We demonstrated 
that iNOS protein was induced in activated CD4+ T cells and 
that use of an iNOS-selective inhibitor, N6-(1-iminoethyl)-
l-lysine dihydrochloride (L-NIL), significantly increased the 
percentage of IL-17–producing CD4+ T cells in cell cultures 
from WT mice, whereas an NO donor, S-nitroso-N-acetyl-
penicillamine (SNAP), dose-dependently suppressed IL-17 
production in WT and iNOS/ T cell cultures. In addition, 
the tyrosine residues of RORt were nitrated resulting in the 
inhibition of RORt-mediated IL-17 promoter activation. 
Figure 2. TH1 and TH2 differentiation in iNOS/ CD4+ T cells. (A) Naive CD4+ T cells from WT or iNOS/ mice were differentiated under TH1 or TH2 con-
ditions for 3 d. Cells were then restimulated with PMA/ionomycin for 5 h and stained for intracellular IFN- or IL-4 by flow cytometry. Each bar represents 
mean ± SD from three independent experiments. (B) Naive CD4+ T cells from spleens and lymph nodes of WT and iNOS/ mice were prepared and the cells 
were activated with anti-CD3 and anti-CD28 antibodies for 3 d. [3H]-Thymidine was added during the last 8 h of culture. Then the cells were collected and were 
counted with a -counter. Alternatively, naive CD4+ T cells were labeled with CFSE and the cells stimulated with plate bound anti-CD3 and anti-CD28 antibod-
ies for 3 d. T cell proliferation was analyzed by flow cytometry. DData represent mean ± SD from two independent experiments, performed in triplicate.
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There were no significant differences between the FOXP3+ 
CD4+ T cell populations of WT and iNOS/ mice under Treg- 
inducing conditions (Fig. 3 A). In addition, production of 
IL-10, another inhibitory cytokine, was comparable in WT 
and iNOS/ TH17 cells (Fig. 3 B). Thus, the enhanced TH17 
cell differentiation in iNOS/ mice was not a result of the 
alterations of either TGF-–derived Treg or IL-10 production.
iNOS is induced in activated CD4+ T cells
The enhanced TH17 cell differentiation of iNOS/ T cells 
cultured under TH17 polarizing conditions prompted us to 
think that iNOS expression in T cells could be responsible 
for reduced TH17 cell differentiation in WT mice. To address 
this question, naive CD4+ T cells from the spleens and lymph 
nodes of WT and iNOS/ mice were activated in vitro for 
3 d under TH0 or TH17 polarizing conditions. Western blot-
ting showed that iNOS protein was indeed induced in WT 
CD4+ T cells but not in iNOS/ T cells (Fig. 4 A). In addi-
tion, stimulation of OT-II cells with OVA peptide (323–339) 
resulted in significant induction of iNOS protein as deter-
mined by Western blotting (Fig. 4 A). Staining cultured 
CD4+ T cells with anti-CD4 and anti-iNOS antibodies dem-
onstrated that CD4+ T cells expressed iNOS after stimulation 
with anti-CD3 and anti-CD28 antibodies (Fig. 4 B). Further-
more, real time RT-PCR experiments revealed the expres-
sion of iNOS mRNA at 6 and 12 h after TCR engagement 
(Fig. 4 C). In addition, single cell FACS analysis showed that 
iNOS was expressed in activated WT CD4+ T cells but not 
in iNOS/ CD4+ T cells (Fig. 4 D), and iNOS/IL-17 double- 
positive cells were present in WT T cells but not in iNOS/  
T cells (unpublished data). To rule out the possibility that 
myeloid cells may have been contaminated in the CD4+  
T cell cultures, we stimulated CD4+ T cells with 1 µg/ml LPS 
for 24 and 48 h and Western blotting was performed. The results 
IL-17, IL-22, and IL-9 secretion by iNOS/ TH17 cells as 
determined by ELISA (Fig. 1 B). In addition, transcript levels 
of the signature TH17 cytokines, IL-17 and IL-21, were sig-
nificantly enhanced in iNOS/ TH17 cells (Fig. 1 C). To rule 
out the possibility that the enhanced TH17 cell differentiation 
was a result of abnormal T cell development, we analyzed 
CD4+ T cells from spleens and lymph nodes of WT and 
iNOS/ mice (Fig. 1 D). In contrast to the dramatic effect of 
iNOS deficiency on TH17 cell differentiation, TH1 and TH2 
differentiation were not noticeably affected in iNOS/ T cell 
cultures (Fig. 2 A). Furthermore, when we polarized naive 
CD4+ T cells under conditions with TGF-/IL-6 plus IL-23, 
we found that IL-17 single-positive cells were significantly 
increased in iNOS/ T cell cultures, but there was no clear 
difference in the number of IFN- single-positive cells be-
tween WT and iNOS/ T cell cultures, whereas IL-17/
IFN- double-positive cells were just minimally increased 
(unpublished data). iNOS/ mice had normal numbers of 
CD4+ T cells (unpublished data) and exhibited comparable 
expression of T cell activation markers CD62L, CD44, CD25, 
and CD69 to relative cells from WT mice (unpublished data). 
In addition, [3H]-thymidine incorporation assays and CFSE 
dilution showed that the proliferation of CD4+ T cells from 
iNOS/ or WT control mice cultured under TH17 condi-
tions was comparable (Fig. 2 B). Collectively, these results 
indicate that TH17 cell differentiation is enhanced in CD4+  
T cells deficient in iNOS, suggesting that NO plays a negative 
role in TH17 cell differentiation.
To investigate whether the enhancement of TH17 cell 
differentiation was the result of Treg dysfunction in iNOS- 
deficient mice, we examined FOXP3+CD4+ T cells in these 
mice. Naive CD4+ T cells from the spleens and lymph nodes 
of WT and iNOS/ mice were activated in vitro for 3 d 
under neutral TH0 or Treg (TGF-) polarizing conditions. 
Figure 3. There are no changes of Treg differentiation and IL-10 production in iNOS/ mice. (A) Naive CD4+ T cells from WT or iNOS/ mice 
were differentiated under TH0 and Treg polarizing conditions for 3 d. Cells were then restimulated with PMA/ionomycin for 5 h, stained for intracellular 
FOXP3, and analyzed by flow cytometry. Representative FACS dot plots gated on CD4+ cells and the percentages of FOXP3-positive CD4+ cells are shown. 
Each represents mean ± SD from three independent experiments. (B) Naive CD4+ T cells from WT or iNOS/ mice were differentiated under TH0 and TH17 
polarizing conditions for 3 d. Cells were then restimulated with PMA/ionomycin for 24 h and the supernatants were analyzed for IL-10 by ELISA. Data 
represent mean ± SD from three independent experiments.
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were primed in vitro for 3 d under TH0 or TH17 polarizing 
conditions. The cells were then restimulated with PMA/
ionomycin and examined for the percentages of IL-17–pro-
ducing cells by intracellular staining using flow cytometry. 
The percentages of IL-17–producing CD4+ T cells from 
eNOS/ and nNOS/ CD4+ T cell cultures were com-
parable to cells from WT cell cultures (unpublished data). 
CD4+ T cells developed normally in eNOS/ and nNOS/ 
mice (unpublished data). These results suggest that iNOS is 
expressed in activated T cells and may play a role in TH17 
cell differentiation.
showed that macrophage cell line 264.7 cells expressed high 
level of iNOS protein after LPS stimulation, whereas LPS-
stimulated CD4+ T cells did not express iNOS protein at all 
(unpublished data). These results suggest that NO derived 
from iNOS expressed by activated CD4+ T cells plays a nega-
tive role in TH17 cell differentiation.
Because T cells have also been reported to express eNOS 
and nNOS (Williams et al., 1998; Ibiza et al., 2006), we 
further wanted to explore whether eNOS or nNOS is in-
volved in the regulation of TH17 cell differentiation. Naive 
CD4+ T cells from eNOS/, nNOS/, and WT mice 
Figure 4. iNOS is expressed in activated CD4+ T cells. (A) Naive CD4+ T cells from WT and iNOS/ mice were stimulated with plate-bound  
anti-CD3 and anti-CD28 antibodies in the presence of 10 ng/ml IL-6 plus 5 ng/ml TGF-. 3 d after stimulation, the cell lysates were collected and iNOS 
protein expression was analyzed by Western blotting. Alternatively, spleen cells were prepared from OT-II mice and the cells were activated with OVA 
peptide at 1.0 µg/ml for different period of time. CD4+ T cells were then purified and iNOS expression was determined by Western blotting. (B) Naive 
CD4+ T cells from B6 mice were stimulated with plate-bound anti-CD3 and anti-CD28 antibodies for 72 h, and cells were fixed and stained for iNOS, 
CD4, and DAPI followed by microscopic analysis. Bars, 100 µm. (C) Naive CD4+ T cells from WT mice were stimulated with plate-bound anti-CD3 and 
anti-CD28 antibodies for various time intervals (6, 12, and 24 h). Total cellular RNA was extracted and iNOS mRNA expression was analyzed by qPCR. 
Each bar represents mean ± SD from three independent experiments. (D) Naive CD4+ T cells from WT and iNOS/ mice were stimulated with plate-
bound anti-CD3 and anti-CD28 antibodies for 72 h, and iNOS expression was analyzed by a single cell flow cytometry. Each bar represents mean ± SD 
from three independent experiments.
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Figure 5. NO suppresses TH17 cell differentiation. (A) Naive CD4+ T cells from B6 mice were differentiated under TH17 polarizing conditions 
in the presence of 0.5 mM L-NIL for 3 d. Cells were then restimulated with PMA/ionomycin for 5 h, stained for intracellular IL-17, and analyzed 
by flow cytometry. Representative FACS dot plots gated on CD4+ cells and the percentages of IL-17–producing CD4+ cells are shown. Each bar 
represents mean ± SD from three independent experiments. *, P < 0.05 versus cells added with L-NIL. (B) The cells prepared in A were differenti-
ated under TH17 polarizing conditions in the presence of SNAP (10, 100, or 200 µM) for 3 d. Cells were then restimulated with PMA/ionomycin 
for 5 h, stained for intracellular IL-17, and analyzed by flow cytometry. Representative FACS dot plots gated on CD4+ cells and the percentages 
of IL-17–producing CD4+ cells are shown. (C) The cells prepared in A were restimulated with PMA/ionomycin for 12 h and the supernatants were 
analyzed for IL-17 by ELISA or the cells prepared in A were restimulated with PMA/ionomycin for 5 h and mRNA expression of indicated genes 
was determined by qPCR. The data shown were normalized to levels of ubiquitin expression as analyzed by qPCR. Each bar presents mean ± SD 
from three independent experiments. *, P < 0.05 versus TH17 cells only. The results are representative of three independent experiments.  
(D) Naive CD4+ T cells from iNOS/ mice were differentiated under TH17 polarizing conditions in the presence of 0.5 mM L-NIL or 100 µM SNAP 
for 3 d. Cells were then restimulated with PMA/ionomycin for 5 h, stained for intracellular IL-17, and analyzed by flow cytometry. Representative FACS 
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The effect of L-NIL, a pharmacologic iNOS inhibitor,  
on TH17 cell differentiation
Experiments with iNOS/ mice indicated that NO may be 
involved in the negative regulation of TH17 cell differentia-
tion. We next tested this by adding an iNOS inhibitor to WT 
T cell cultures. We used L-NIL, a selective iNOS inhibitor, 
to treat CD4+ T cells cultured under TH17 conditions. Naive 
CD4+ T cells from spleens and lymph nodes of WT mice 
were activated in vitro for 3 d under TH17 polarizing condi-
tions in the presence of 0.5 mM L-NIL. Addition of L-NIL 
significantly enhanced the percentage of IL-17–producing 
cells and IL-17 protein release in WT CD4+ T cell cultures 
(Fig. 5 A), which mimicked the iNOS/ CD4+ T cell 
cultures. We next used SNAP, which releases NO spontane-
ously and is widely used as an NO donor. SNAP dose- 
dependently reduced the percentage of IL-17–producing 
CD4+ T cells (Fig. 5 B). Similarly, IL-17 protein release and 
IL-17 mRNA expression were inhibited by SNAP in a dose- 
dependent manner (Fig. 5 C). In addition, SNAP suppressed 
TH17 cell differentiation in both WT and iNOS/ cell cul-
tures, whereas L-NIL had no significant effect on the per-
centage of IL-17–producing cells and IL-17 protein release in 
iNOS/ CD4+ T cell culture (Fig. 5 D). Furthermore, we also 
used 2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide 
(PTIO), an NO scavenger. We demonstrated that PTIO treat-
ment significantly increased the percentage of IL-17–producing 
CD4+ T cells in WT T cell cultures but not in iNOS/  
T cell cultures (Fig. 6). To test whether L-NIL and SNAP 
affects TH1 or TH2 cell differentiation, naive CD4+ T cells 
from spleens and lymph nodes of WT mice were activated 
in vitro for 3 d under TH1 or TH2 conditions in the presence 
of 0.5 mM L-NIL or 50 µM SNAP. We did not find a signif-
icant effect of L-NIL or SNAP on TH1 or TH2 cell differen-
tiation (unpublished data). In addition, the compound SNAP 
or L-NIL had no significant effect on cell viability and prolif-
eration (unpublished data). Thus, these results suggest that 
NO derived from iNOS expressed in T cells selectively in-
hibits TH17 cell differentiation.
NO suppresses RORt-mediated IL-17 transcription
The above findings prompted us to probe the molecular basis 
for NO control of TH17 cell differentiation. Because many 
studies have demonstrated a critical role for RORt in TH17 
cell differentiation both in vitro and in vivo (Ivanov et al., 
2006), we asked if NO might affect RORt expression, re-
sulting in the control of TH17 cell differentiation. First we 
examined RORt expression in iNOS-deficient CD4+  
T cells. Naive CD4+ T cells from iNOS/ or WT littermate 
mice were primed in vitro for 3 d under TH0 or TH17 polarizing 
conditions. The cells were then restimulated with PMA/iono-
mycin and examined for the percentages of RORt-positive 
cells by intracellular staining using flow cytometry. Interestingly, 
the percentage of RORt-positive cells in iNOS/ CD4+  
T cell cultures was comparable to that in WT cell cultures 
(Fig. 7 A). This was confirmed by Western blotting experiments 
showing that the levels of RORt, STAT3, IRF4, and AHR 
protein were similar in iNOS/ and WT mice (Fig. 7 B). 
These results suggest that enhanced TH17 cell differentiation in 
iNOS/ mice is not the result of a change in RORt expres-
sion at the protein level. To further assess whether NO might 
directly affect RORt protein expression, we transfected 
RORt into 293T cells treated with different concentrations 
of SNAP for 40 h and then examined RORt expression by 
Western blotting. The results showed that the treatment with 
SNAP did not affect the levels of RORt expression (Fig. 7 C) 
or nuclear translocation (Fig. 7 C).
We then proceeded to analyze whether NO modulates 
posttranslational modification of RORt protein. First, we 
considered if NO affects RORt ubiquitination. To test this, 
we cotransfected T7-RORt and HA-ubiquitin overexpres-
sion plasmids into 293T cells in the presence of the NO 
donor SNAP at different concentrations for 40 h. Cell lysates 
were analyzed by immunoprecipitation with anti-T7 anti-
body and immunoblotted with anti-HA mAb. A high mo-
lecular mass smear typical of ubiquitinated protein was 
detected only in samples cotransfected with T7-RORt and 
HA-ubiquitin. SNAP treatment had no significant effect on 
Figure 6. NO suppresses TH17 cell differentiation. Naive CD4+ T cells 
from WT or iNOS/ mice were differentiated under TH17 polarizing con-
ditions in the presence of 200 µM PTIO for 3 d. Cells were then restimu-
lated with PMA/ionomycin for 5 h, stained for intracellular IL-17, and 
analyzed by flow cytometry. Representative FACS dot plots gated on CD4+ 
cells and the percentages of IL-17–producing CD4+ cells are shown. The 
data are representative of three similar experiments.
dot plots gated on CD4+ cells and the percentages of IL-17–producing CD4+ cells are shown. Or the cells were restimulated with PMA/ionomycin 
for 12 h and the supernatants were analyzed for IL-17 by ELISA. The results are representative of three independent experiments.
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binding to the promoter region of IL-17 gene (Fig. 7 E), 
whereas L-NIL treatment significantly enhanced the binding 
of RORt there (Fig. 7 E). To further analyze the effect of 
NO on nitration of tyrosine residues in RORt, we per-
formed coimmunoprecipitation experiments using cell lysates 
from primary CD4+ T cells cultured under TH0 or TH17 
conditions. We found that anti-nitrotyrosine antibody coim-
munoprecipitated RORt from lysates of TH17 cells (Fig. 8 A), 
suggesting that tyrosine residues of RORt were nitrated 
under TH17 conditions. To confirm these results, 293T cells 
were transfected with T7-RORt in the presence of SNAP 
for 40 h. Cell lysates were immunoprecipitated with anti- 
nitrotyrosine antibody and immunoblotted with anti-T7 an-
tibody. SNAP treatment clearly induced tyrosine nitrosylation 
the pattern of ubiquitination (unpublished data), suggesting 
that RORt ubiquitination is not the target for the effect of 
NO on RORt.
The mouse amino acid sequence of RORt has 15 tyro-
sine residues (unpublished data), which may be subject to ni-
tration induced by NO. To investigate this possibility, naive 
CD4+ T cells from spleens and lymph nodes of WT mice 
were activated in vitro for 3 d under TH17 conditions in the 
presence of L-NIL or SNAP. Flow cytometric analyses clearly 
revealed a population of RORt+Nitrotyrosine+ cells in WT 
but not in iNOS/ cell cultures (Fig. 7 D). Treatment with 
SNAP resulted in an expansion of this cell population (Fig. 7 D), 
which was reversed in the presence of L-NIL (Fig. 7 D). ChIP 
analysis indicated that SNAP treatment suppressed RORt 
Figure 7. NO suppresses RORt-mediated IL-17 transcription. (A) Naive CD4+ T cells from WT or iNOS/ mice were differentiated under TH17 polar-
izing conditions for 3 d. Cells were then restimulated with PMA/ionomycin for 5 h, stained for intracellular RORt, and analyzed by flow cytometry. Represen-
tative FACS dot plots gated on CD4+ cells and the percentages of RORt-positive CD4+ cells are shown. (B) The cells prepared in A were lysed and cell lysates 
were prepared. The expression of RORt and other indicated proteins was analyzed by Western blotting. (C) 293T cells were transfected with T7-tagged 
RORt plasmid for 40 h in the presence of SNAP (10, 50, 100, or 200 µM). Cell lysates were collected and RORt protein expression was analyzed by Western 
blotting. Alternatively, 293T cells were transfected with T7-tagged RORt plasmid for 40 h in the presence of 100 µM SNAP. Nuclear protein was extracted 
and RORt protein expression was analyzed by Western blotting. (D) Naive CD4+ T cells from WT or iNOS/ mice were differentiated under TH17 polarizing 
conditions in the presence of 50 µM SNAP or 0.5 mM L-NIL for 3 d. Cells were then restimulated with PMA/ionomycin for 5 h, stained for intracellular RORt 
and nitrotyrosine, and analyzed by flow cytometry. Representative FACS dot plots are gated on CD4+ cells. (E) Naive CD4+ T cells from WT mice were cultured 
under TH17-polarizing conditions in the presence of 50 µM SNAP or 0.5 mM L-NIL for 60 h, followed by ChIP assay. 3 µg anti-RORt antibody or isotype-
matched IgG as control antibody were used in the immunoprecipitation step. PCR was used to quantify the amount of precipitated DNA with primers flank-
ing the CNS2 and 250 to 50 regions of the IL-17 promoter. Each bar represents mean ± SD from three independent experiments.
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RORt truncation mutants 169-491 and 342-491 (Fig. 8 C). 
Thus, tyrosine residues in the region from residue 169 to 491 
of RORt are sensitive to nitration by NO. Because NADPH 
oxidase is required for the formation of peroxynitrite, which 
is involved in the tyrosine nitration, we found that T cells 
expressed NAPDH p47-phox (unpublished data), as reported 
previously (Jackson et al., 2004). To examine the effect of 
NO on RORt at the functional level, we cotransfected an 
IL-17 promoter reporter and RORt expression plasmids 
into 293T cells in the presence of various doses of SNAP for 
of RORt (Fig. 8 B), suggesting that NO-induced altera-
tions of tyrosine residues may affect RORt activation. To 
analyze which part of RORt is sensitive to NO, we gener-
ated three T7-tagged RORt truncation mutants (5-166, 
169-491, and 342-491). The mutants were transfected 
into 293T cells in the presence of SNAP for 40 h and cell 
lysates were immunoprecipitated with anti-nitrotyrosine an-
tibody and immunoblotted with anti-T7 antibody. SNAP 
treatment had no significant effect on RORt mutant 5-
166 (Fig. 8 C) but clearly increased nitrotyrosine levels of 
Figure 8. NO suppresses RORt-medi-
ated IL-17 transcription. (A) Naive CD4+  
T cells from B6 mice were cultured under TH0 
or TH17-polarizing conditions for 60 h and the 
cell lysates were then immunoprecipitated 
with an anti-nitrotyrosine antibody and blotted 
with anti-RORt. Data are representative  
of three independent experiments. (B) 293T 
cells were transfected with T7-tagged RORt 
plasmid for 40 h in the presence of 100 µM 
SNAP. Cell lysates were immunoprecipitated 
with anti-nitrotyrosine antibody and immuno-
blotted with anti-T7 antibody. (C) 293T cells 
were transfected with T7-tagged RORt trun-
cation mutant plasmids (5-166, 169-491, 
and 342-491) for 40 h in the presence of 
100 µM SNAP. Cell lysates were immunopre-
cipitated with anti-nitrotyrosine antibody  
and immunoblotted with anti-T7 antibody.  
(D) 293T cells were cotransfected with an IL-17A 
promoter reporter construct containing the  
6-kb promoter and a RORt plasmid in the 
presence of SNAP (50, 100, or 200 µM) or 
293T cells were transfected with an IL-17A 
promoter reporter construct and WT RORt or 
different RORt mutant plasmids for 30 h. 
Luciferase assays were performed and lucifer-
ase activities were normalized to -galactosi-
dase activity. Data indicate mean ± SD of 
triplicate cultures and are representative of 
three independent experiments.
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Figure 9. iNOS deficiency promotes the TH17 immune responses in experimental colitis. CD4+CD45RBhi T cells were purified from spleens and lymph 
nodes of WT or iNOS/ mice and 5 × 105 cells were injected (i.p.) into recipient Rag1/ mice. Body weight change was monitored every week and mice were 
sacrificed 5 wk later. (A) Changes in body weight of Rag1/ mice (n = 5–6 mice per group) after i.p. transfer of WT or iNOS/ CD4+CD45RBhi T cells were recorded. 
Data are presented as the mean ± SD of the percentage of initial body weight and are representative of two similar experiments. *, P < 0.05 versus recipients of 
iNOS/ cells. Morphology of intestines (B), disease scores (C; each bar represents mean ± SD of measurements made from five mice; *, P < 0.05 versus recipients  
of iNOS/), and sections of colons with colitis (D) from Rag1/ mice (n = 5–6 mice in each group) on day 35 after naive T cell transfer was as described above. 
Bars, 100 µm. (E) The percentage of IL-17–producing cells from mesenteric lymph nodes of Rag1/ mice in B, C, and D (white column, transfer with WT cells; black 
column, transfer with iNOS/ cells). Each bar represents mean ± SD of measurements made from five mice. *, P < 0.05 versus recipients of iNOS/ cells.
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36 h and analyzed them for IL-17 promoter activation. The 
data showed that SNAP suppressed RORt-mediated IL-17 
promoter activation in a dose-dependent manner (Fig. 8 D). 
Furthermore, we have analyzed two tyrosine residues Tyr346 
and Tyr359 of mouse RORt, corresponding to Tyr369 and 
Tyr382 of human RORt, that are important for ligand 
binding (Fig. S1, A and B). We found that mutating these 
two tyrosine residues significantly impaired RORt-mediated 
IL-17 promoter activation, suggesting that Tyr346 and Tyr359 
are critical for RORt transcriptional function (Fig. 8 D). 
Thus, the results indicate that NO suppresses IL-17 expres-
sion at the transcriptional level by nitration of tyrosine resi-
dues in RORt.
iNOS regulates TH17 cell differentiation in vivo
Accumulating evidence indicates that TH17 cells are involved 
in the pathogenesis of various autoimmune/inflammatory 
diseases, including MS, RA, IBD, and asthma (Weaver et al., 
2006; Wilke et al., 2011). To further assess the effects of iNOS 
on TH17 cell development in vivo, we performed adoptive 
transfer experiments using CD4+CD45Rbhi cells from WT 
and iNOS/ mice to induce colitis in Rag1/ mice. Rag1/ 
mice reconstituted with iNOS/ T cells began losing weight 
earlier and lost significantly more weight than mice transferred 
with WT cells (Fig. 8 A). Parallel histological studies of colon 
sections from Rag1/ mice reconstituted with iNOS/  
T cells revealed more severe inflammatory cell infiltrates and 
significantly higher pathological scores than those observed in 
sections from mice reconstituted with T cells from WT mice 
(Fig. 9, B–D). In addition, mice reconstituted with iNOS/ 
cells had significantly higher percentages of IL-17–producing 
cells than control mice (Fig. 8 E), whereas the percentage of 
IFN-–producing cells was comparable (Fig. 9 E). Thus, 
iNOS deficiency in T cells promotes intestinal inflammation 
in a T cell–mediated model of colitis, suggesting that iNOS 
expressed in T cells may play a negative role in the regulation 
of TH17 immune response.
To further understand the role of iNOS in TH17 cell func-
tion in vivo, we extended our studies to include experimen-
tal autoimmune encephalomyelitis (EAE), a mouse model of 
human MS. Previous studies showed that NO will suppress 
EAE (Zielasek et al., 1995; Okuda et al., 1997; Fenyk-Melody 
et al., 1998). To investigate the role of iNOS expressed by 
T cells on the development of EAE, we immunized WT and 
iNOS/ mice with the myelin oligodendrocyte glycoprotein 
(MOG35-55) peptide in complete Freund’s adjuvant. iNOS/ 
mice developed EAE with an accelerated time course and 
greater severity than WT mice as indicated by disease scores 
(Fig. 10 A). As expected, iNOS mRNA expression was signif-
icantly induced in CD4+ T cells from WT but not from 
iNOS/ mice in these experiments (Fig. 10 B). We then 
examined the expression of TH17 and TH1 cytokines in EAE 
mice. Infiltrating CD4+ T cells from the central nervous sys-
tems of iNOS-deficient mice with EAE expressed significantly 
higher percentage of IL-17–producing and IFN-–producing 
CD4+ T cells and expressed higher levels of transcripts for 
IL-17 and IFN- compared with cells from WT mice (Fig. 10, 
C and D). Thus, iNOS deficiency promotes inflammation in 
central nervous system in EAE, further confirming that NO 
negatively regulates TH17 cell differentiation in vivo.
DISCUSSION
TH17 cells are a new member of the still-growing family of 
T helper cell subsets, which play critical roles in the pathogenesis 
of autoimmune and inflammatory diseases. Therefore, under-
standing the intrinsic suppressing programs for TH17 cells will 
help to dissect mechanisms for the control of TH17 immune re-
sponses and elucidate the mechanism involved in the develop-
ment of human inflammatory diseases including IBD, MS, and 
RA. In the present study, we demonstrated that iNOS-deficient 
naive CD4+ T cells polarized under TH17 condition led to more 
efficient TH17 cell differentiation without major effects on 
either the TH1 or TH2 cell lineages. In vivo, transfer of CD4+ 
CD45RBhi cells into Rag1/ mice induced more severe colitis 
than transfer of control cells. In addition, mice reconstituted 
with iNOS/ T cells had a significantly higher percentage of 
IL-17–producing CD4+ T cells than mice transferred with 
WT cells. These results suggest that iNOS derived from acti-
vated T cells selectively regulates T cell differentiation.
Many studies have demonstrated that NO can play a dual 
role in the modulation of immune responses (Niedbala et al., 
2006). NO derived from iNOS in macrophages and other in-
nate immune cells is proinflammatory and an essential compo-
nent of host defenses against various pathogens including 
bacteria, parasites, and viruses (Bogdan et al., 2000). However, 
mounting evidence indicates that NO can also contribute 
to immune suppression. We and other groups previously re-
ported that IL-12 mRNA and protein expression were signif-
icantly increased in iNOS KO mice, suggesting that NO may 
suppress IL-12–mediated TH1 immune responses (Xiong 
et al., 2004). Huang et al. ( 1998) suggested that the enhanced 
TH1 immune responses in iNOS KO mice were a result of 
increased production of IL-12 by iNOS/ macrophages after 
infection with Leishmania major. In addition, Giordano et al. 
(2011) reported that expression of inflammatory cytokines, 
including TNF, IL-6, IL-12p70, and IL-23, was up-regulated 
in iNOS/ bone marrow–derived dendritic cells. Collec-
tively, these results indicate that iNOS expressed in innate 
immune cells, including macrophages and dendritic cells, can 
modulate inflammatory cytokine production. Although the 
exact molecular mechanisms responsible for this regulation are 
not fully understood, NO-mediated control of NF-B activa-
tion may be involved (Xiong et al., 2004).
It is well established that iNOS is expressed in different 
cell types including, macrophages, dendritic cells, NK cells, 
and by both primary tumor cells and tumor cell lines (Bogdan., 
2001). In addition, there is a controversy for the expression 
of iNOS in T cells. Vig et al. (2004) reported that T cell blasts 
expressed iNOS, which plays an important role in immune 
memory, whereas Thüring et al. (1995) did not find iNOS 
expression in T cells clones or T cells from naive and L. major–
infected mice. In the present study, we clearly demonstrated 
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lymph nodes or Peyer’s patches and TH17 cell development is 
severely impaired, indicating that RORt is a master tran-
scription factor in TH17 cell differentiation (Ivanov et al., 
2006). Interestingly, RORt expression in iNOS/ CD4+ 
T cells cultured under TH17 conditions was comparable to 
WT CD4+ T cell cultures, implying that the enhanced TH17 
cell differentiation observed is not the result of increased 
RORt protein levels. Instead, we found that the NOS 
donor SNAP suppressed RORt-mediated IL-17 promoter 
activation in a dose-dependent manner, suggesting that NO 
that iNOS expressed by activated CD4+ T cells negatively 
regulated TH17 cell differentiation. The results are consistent 
with recent studies showing that the NO donors NOC-18 
and S-nitrosoglutathione suppressed TH17 cell differentiation 
(Nath et al., 2010; Niedbala et al., 2011). Thus, our observa-
tions support the notion that NO derived from iNOS in 
activated T cells controls T cell differentiation by selectively 
suppressing TH17 cell development.
The importance of RORt in TH17 cell development has 
been well studied in mice. RORt/ mice fail to develop 
Figure 10. iNOS is expressed in CD4+ T cells infiltrated in CNS of WT mice with EAE and iNOS/ mice develop more severe EAE.  
(A) iNOS/ or WT mice were induced for EAE, and disease development was scored. Data are mean ± SD (n = 15 mice per group) pooled from three ex-
periments. The score was based on a five-point scale. (B) CD4+ T cells were purified from CNS of WT and iNOS/ mice with EAE. Total RNA was extracted 
and iNOS mRNA expression was determined by qPCR. Each bar represents mean ± SD from two independent experiments. (C) WT or iNOS/ mice were 
induced for EAE and CD4+ T cells were purified from CNS of iNOS/ or WT mice with EAE. Cells were then restimulated with PMA/ionomycin for 5 h, 
stained for intracellular IL-17 or IFN-, and analyzed by flow cytometry. Representative FACS dot plots gated on CD4+ cells and the percentages of IL-17–
producing or IFN-–producing CD4+ cells are shown. (D) WT or iNOS/ mice were induced for EAE and CD4+ T cells were purified from CNS of iNOS/ 
or WT mice with EAE. Total RNA was extracted and qPCR was performed for the analysis of IL-17, IFN-, and CCR6 mRNA expression. Each bar represents 
mean ± SD from three independent experiments. *, P < 0.05 versus WT cells.
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Consistent with our in vitro results, iNOS transcripts were 
highly induced in T cells infiltrating the CNS of WT but 
not iNOS/ mice with EAE. Interestingly, we found that 
IFN-–producing CD4+ T cells were significantly increased in 
iNOS/ mice with EAE compared with WT mice with EAE, 
in a similar pattern to IL-17–producing CD4+ T cells. Because 
in this EAE model iNOS can be expressed by different cell 
types, including macrophages, dendritic cells, microglias, and 
T cells, it is therefore still not clear which iNOS-expressing cell 
contributes to the regulation of TH1 cells. Collectively, iNOS 
expressed by activated T cells selectively regulates TH17 cell 
development, resulting in the control of diseases development 
in colitis and EAE models.
Collectively, our studies clearly demonstrate that iNOS is 
expressed in activated CD4+ T cells, and NO derived from 
iNOS in activated CD4+ T cells suppresses TH17 cell develop-
ment. Based on these observations, we suggest a novel molecu-
lar mechanism for the inhibitory effects of NO on TH17 
differentiation that involves the suppression of RORt activa-
tion. Our results support the concept that iNOS expressed by 
T cells may play an important role in the development of in-
flammatory diseases by controlling TH17 immune responses.
MATERIALS AND METHODS
Mice. C57BL/6J (B6, stock#000664) and iNOS-deficient mice (B6.129P2-
Nos2tm1Lau/J, stock#002609) were obtained from The Jackson Laboratory and 
maintained in the barrier facility at the Mount Sinai School of Medicine. 
eNOS-deficient mice (B6.129P2-Nos3tm1unc/J, stock#002684) and nNOS/ 
mice (B6.129S4-Nos1tm2pih/J, stock#008519) were derived from The Jackson 
Laboratory. The animal study protocols were approved by the Institutional 
Animal Care and Use Committees of Mount Sinai School of Medicine.
Antibodies. The following antibodies were purchased from BD, as conju-
gated to FITC, PE, PE-Cy5, perCP-Cy5.5, or APC: CD4 (L3T4), NOS2 
(6/iNOS/NOS typeII), CD8 (53–6.7), CD3e (145-2C11), CD25 (PC61.5), 
CD44 (IM7), CD62L (MEL-14), CD45RB (C363-16A), IL-17 (TC11-
18H10), IFN- (XMG1.2), and isotype controls. Antibodies for nitrotyro-
sine (1A6) and p47phox (mouse) were purchased from EMD Millipore. 
Antibodies for IL-2 (JES6-1A12), ROR (B2D), IL-4 (11B11), IL-10 
(JES5-16E3), and Foxp3 (FJK-16S) were purchased from eBioscience. Anti-
body for AHR (BML-SA210) was purchased from Enzo Life Sciences. 
Antibodies for NOS1 (K-20), NOS2 (M-19), and NOS3 (C-20) were pur-
chased from Santa Cruz Biotechnology, Inc.
CD4+ T cell preparation and differentiation in vitro. Naive CD4+  
T cells (CD62L+CD44lo) were prepared by fluorescence-activated cell sort-
ing from spleens and lymph nodes of iNOS/ and WT littermates. The 
sorted cells were primed for 96 h with 1 µg/ml anti-CD3 (145-2C11; BD) 
and 2 µg/ml of soluble anti-CD28 (37.51; BD). The cells were rested for 
48 h and were then restimulated for 5 h with PMA plus ionomycin in the 
presence of brefeldin A, and intracellular cytokines were measured by flow 
cytometry. Cells stimulated under neutral conditions were defined as TH0 
cells. Cells were stimulated to differentiate into TH1 cells by supplementa-
tion with IL-12 plus anti–IL-4 or into TH2 cells by supplementation with 
IL-4 and anti–IFN-. For TH17 cell differentiation, cells were stimulated 
with 5 ng/ml TGF-1, 20 ng/ml IL-6, 10 ng/ml and IL-23 (all from R&D 
Systems) in the presence of 10 µg/ml anti–IL-4 antibody (11B11; BD) and 
10 µg/ml anti–IFN- antibody (XMG1.2, BD).
Intracellular staining and flow cytometry. Cells were stimulated with 
PMA and ionomycin for 5 h in the presence of brefeldin A before intracel-
lular staining. Cells were fixed with IC Fixation Buffer (BD), incubated with 
may control RORt activity during IL-17 gene transcription. 
How might NO control RORt activity? NO has been 
shown to directly affect the activity of many proteins via tyro-
sine nitration. We have clearly shown that tyrosine residues in 
RORt are nitrated and that such nitration of RORt signif-
icantly impaired the binding of RORt to the promoter re-
gion of the IL-17 gene resulting in the inhibition of IL-17 
transcription. Our RORt mutant studies showed the tyro-
sine residues between amino acids 169 and 491 are possible 
targets for nitration by NO. Combined with our knowledge 
of the human RORt crystal structure and its ligand binding 
domain with digoxin (Fig. S1), we found that several tyrosine 
residues are indeed in this region, with Tyrosine369 and 
Tyrosine382 being located near the ligand binding pocket. As 
such, the tyrosine nitration may well affect RORt ligand 
binding activity and formation. Our further mutation ex-
periments demonstrated that Tyr346 and Tyr359 of mouse 
RORt, corresponding to Tyr369 and Tyr382 residues of 
human RORt, are critical for RORt transcriptional activa-
tion. Thus, the results suggest that Tyr346 and Tyr359 could 
be the target for NO on RORt transcriptional function. 
Recently, Niedbala et al. (2011) reported that NO donor 
NOC-18 inhibits AHR protein expression in TH17 cells, and 
they conclude that NO suppresses TH17 cell development by 
inhibiting AHR protein expression. However, we did not find 
significant difference of AHR protein expression in WT and 
iNOS/ CD4+ T cells under TH17 conditions, suggesting 
that AHR protein expression does not explain the effect of 
T cell–derived iNOS on TH17 cell differentiation.
A previous study showed that tyrosines of IB are nitrated 
as a consequence of NO synthase activation, leading to dissoci-
ation of IB from NF-B (Yakovlev et al., 2007). Other 
studies have shown that nitration of a specific tyrosine in 
proteins can have structural and functional significance (Radi, 
2004; Ischiropoulos and Gow., 2005; Ji et al., 2006). Thus, our 
study documents a novel mechanism for the regulation of TH17 
cell development by nitration of RORt tyrosine residues. In 
addition, nitrosylation has also been reported to regulate the 
activation of transcription factors (Pannu and Singh., 2006; 
Prasad et al., 2007). Khan et al. (2005, 2006) reported that a 
physical NO carrier, GSNO, regulates NF-B activation via 
S-nitrosylation of p65, which limits its binding activity. Our 
future studies explore whether S-nitrosylation of RORt is 
also involved in the regulation of IL-17 transcription.
It has been demonstrated that TH17 cells play critical roles 
in the pathogenesis of several inflammatory diseases, including 
IBD and MS (Weaver et al., 2006; Wilke et al., 2011). In the 
present study, we demonstrated that iNOS derived from 
T cells targets RORt, resulting in impaired TH17 cell devel-
opment. We demonstrated that transfer of iNOS/ naive 
CD4+ T cells into Rag1/ mice induced more severe colitis 
with an enhanced TH17 immune response. In addition, 
iNOS/ mice developed more severe EAE than WT mice, 
consistent with previous studies (Zielasek et al., 1995; Okuda 
et al., 1997; Fenyk-Melody et al., 1998; Niedbala et al., 2011), 
and IL-17 expression was significantly higher in iNOS/ mice. 
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3 µg of anti-ROR (Santa Cruz Biotechnology, Inc.) or control antibody. 
Cross-linking was reversed at 65°C for 4 h, followed by proteinase K diges-
tion. DNA was purified and subjected to qPCR. The input DNA was di-
luted 200× before PCR amplification. The input and immunoprecipitated 
DNA were amplified by qPCR using primers encompassing the CNS2 and 
50 to 250 regions of the mouse IL-17 promoter.
Induction of experimental autoimmune encephalomyelitis (EAE). 
iNOS/ and WT mice were immunized subcutaneously with 200 µl emul-
sion containing 100 µg myelin oligodendrocyte glycoprotein (MOG)35-55 
peptide (MEVGWYRSPFSRVVHLYRNGK), complete Freund’s adjuvant, 
and 0.4 mg Mycobacterium tuberculosis extract H37-Ra (Difco). Mice were 
given 100 ng pertussis toxin (list Biological Laboratories) intraperitoneally on 
days 0 and 2. Mice were sacrificed 3 wk later. EAE was scored as follows: 
0, no diseases; 1, limp tail; 2, hind limb weakness; 3, partial paralysis and hind 
limb paralysis; 4, front and hind limb paralysis; 5, death.
Cytokine ELISA. Supernatants from cell cultures were collected after acti-
vation under various conditions and secreted cytokines in the supernatants 
were measured by ELISA kits with purified coating and biotinylated detec-
tion antibodies anti-IL-17 (R&D Systems) and anti–IL-10 (BD).
Statistical analysis. Statistical analysis was performed using Student’s t test. 
P-values <0.05 were considered statistically significant.
Online supplemental material. Fig. S1 shows structural analysis of the 
ligand-binding domain of RORt. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20122494/DC1.
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with an oligo (dT) primer and the Superscript II system (Invitrogen), followed 
by analysis using iCycler PCR with SYBR Green PCR master Mix (Applied 
Biosystems). Results were normalized based on the expression of ubiquitin. 
The following primer sets were used: IL-17A sense, 5-CTCCAGAAGGC-
CCTCAGACTAC-3; IL-17A antisense, 5-AGCTTTCCCTCCGC-
ATTGACACAG-3; IL-21 sense, 5-CGCCTCCTGATTAGACTTCG-3; 
IL-21 antisense, 5-GCCCCTTTACATCTTGTGGA-3; RORt sense, 
5-CCGCTGAGAGGGCTTCAC-3; RORt antisense, 5-TGCAG-
GAGTAGGCCACATTACA-3; iNOS sense, 5-CCGAAGCAAACAT-
CACATTCA-3; iNOS antisense, 5-GGTCTAAAGGCTCCGGGCT-3; 
ubiquitin sense, 5-TGGCTATTAATTATTCGGTCTGCA-3; and ubiq-
uitin antisense, 5-GCAAGTGGCTAGAGTGCAGAGTAA-3.
Transfection and luciferase reporter assay. 293T cells were transiently 
transfected with an IL-17 promoter luciferase reporter plasmid together with 
RORt in the presence of SNAP at different concentrations. For each trans-
fection, 2.0 µg of plasmid was mixed with 100 µl DMEM (without serum 
and antibiotics) and 4.0 µl Lipofectamine 2000 reagent. The mixture was in-
cubated at room temperature for 20 min and added to 12-well plates con-
taining cells and complete medium. The cells were incubated for 30 h and 
harvested using reporter lysis buffer (Promega) for determination of lucifer-
ase activity. Cells were cotransfected with a -galactosidase reporter plasmid 
to normalize experiments for transfection efficiency.
T cell proliferation assay. Naive CD4+ T cells were purified from spleens and 
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